Muller WJ - Search Results

1

Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer.

Howe LR, Subbaramaiah K, Patel J, Masferrer JL, Deora A, Hudis C, Thaler HT, Muller WJ, Du B, Brown AM, Dannenberg AJ. Howe LR, et al. Among authors: muller wj. Cancer Res. 2002 Oct 1;62(19):5405-7. Cancer Res. 2002. PMID: 12359744

2

Transgenic models of breast cancer metastasis.

Dankort DL, Muller WJ. Dankort DL, et al. Among authors: muller wj. Cancer Treat Res. 1996;83:71-88. doi: 10.1007/978-1-4613-1259-8_4. Cancer Treat Res. 1996. PMID: 8826642 Review. No abstract available.

3

The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.

Rudolph-Owen LA, Chan R, Muller WJ, Matrisian LM. Rudolph-Owen LA, et al. Among authors: muller wj. Cancer Res. 1998 Dec 1;58(23):5500-6. Cancer Res. 1998. PMID: 9850086

4

The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis.

Kim H, Muller WJ. Kim H, et al. Among authors: muller wj. Exp Cell Res. 1999 Nov 25;253(1):78-87. doi: 10.1006/excr.1999.4706. Exp Cell Res. 1999. PMID: 10579913 Review.

5

Tyrosine kinase signalling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer.

Andrechek ER, Muller WJ. Andrechek ER, et al. Among authors: muller wj. Breast Cancer Res. 2000;2(3):211-6. doi: 10.1186/bcr56. Epub 2000 Apr 12. Breast Cancer Res. 2000. PMID: 11250712 Free PMC article. Review.

6

Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis.

Siegel PM, Shu W, Cardiff RD, Muller WJ, Massagué J. Siegel PM, et al. Among authors: muller wj. Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8430-5. doi: 10.1073/pnas.0932636100. Epub 2003 Jun 13. Proc Natl Acad Sci U S A. 2003. PMID: 12808151 Free PMC article.

7

The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.

D'Amico M, Wu K, Di Vizio D, Reutens AT, Stahl M, Fu M, Albanese C, Russell RG, Muller WJ, White M, Negassa A, Lee HW, DePinho RA, Pestell RG. D'Amico M, et al. Among authors: muller wj. Cancer Res. 2003 Jun 15;63(12):3395-402. Cancer Res. 2003. PMID: 12810676

8

Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers.

Andrechek ER, Laing MA, Girgis-Gabardo AA, Siegel PM, Cardiff RD, Muller WJ. Andrechek ER, et al. Among authors: muller wj. Cancer Res. 2003 Aug 15;63(16):4920-6. Cancer Res. 2003. PMID: 12941816

9

Angiogenic acceleration of Neu induced mammary tumor progression and metastasis.

Oshima RG, Lesperance J, Munoz V, Hebbard L, Ranscht B, Sharan N, Muller WJ, Hauser CA, Cardiff RD. Oshima RG, et al. Among authors: muller wj. Cancer Res. 2004 Jan 1;64(1):169-79. doi: 10.1158/0008-5472.can-03-1944. Cancer Res. 2004. PMID: 14729621

10

Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.

Hutchinson JN, Jin J, Cardiff RD, Woodgett JR, Muller WJ. Hutchinson JN, et al. Among authors: muller wj. Cancer Res. 2004 May 1;64(9):3171-8. doi: 10.1158/0008-5472.can-03-3465. Cancer Res. 2004. PMID: 15126356

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

386 results

Search Page

Filters